/SDMHF

SDMHF Stock - Sartorius Stedim Biotech S.A.

Q: What is the analyst price target for SDMHF?

Analyst price target information is not currently available for SDMHF.

Q: What is SDMHF's market cap?

Market capitalization information is not currently available for SDMHF.

Healthcare|Medical - Instruments & Supplies|OTC

$240.00+0.00%

+$0.00 (+0.00%) • Dec 19

GoAI Score

Weighted average: Momentum (25%) + Sentiment (35%) + Risk (20%) + Value (20%). ≥70 = BUY, ≤35 = SELL.

HOLD

Medium Confidence

Momentum

Momentum Score

Based on price vs 50-day MA (40%), 200-day MA (40%), and MA crossover (20%). Higher = stronger uptrend.

Sentiment

Sentiment Score

Based on analyst price target upside. 50 = neutral, 100 = very bullish (25%+ upside expected).

Risk Score

Based on stock beta (volatility). Higher score = lower risk. Red (<40) = high volatility, Green (>60) = stable.

Price Target

Average analyst price target from the last quarter. Shows expected upside/downside from current price.

+10.0%upside

Target: $264.00

AI Analysis PreviewPremium

Real-time AI-powered market analysis

Precise entry/exit price targets

Risk assessment & position sizing

Unlock GoAI Insights for SDMHF

Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.

Buy/Sell Signals

94% win rate on Alpha signals

Deep Analysis

Institutional-grade thesis

Real-Time Alerts

SMS & push notifications

Risk Scoring

Multi-factor analysis

Free 14-day trial • No credit card required

Financial Statements

Revenue & Profitability Trend

FY2020

FY2021

FY2022

FY2023

FY2024

← Swipe to see more →

Revenue

Net Income (Profit)

Net Loss

Key Metrics

Market CapN/A

P/E RatioN/A

Beta1.26

52W High$251.50

52W Low$170.00

Avg VolumeN/A

Income Statement (Fiscal Year)

Metric	FY2024	FY2023	FY2022	FY2021	FY2020
Revenue	$2.78B	$2.78B	$3.49B	$2.89B	$1.91B
Gross Profit	$1.21B	$1.23B	$1.83B	$1.55B	$1.00B
Gross Margin	43.4%	44.4%	52.5%	53.8%	52.5%
Operating Income	$370.60M	$449.50M	$995.20M	$865.42M	$471.81M
Net Income	$175.10M	$309.70M	$876.10M	$414.40M	$335.93M
Net Margin	6.3%	11.2%	25.1%	14.4%	17.6%
EPS	$1.81	$3.36	$9.51	$4.50	$3.64

Company Overview

Sartorius Stedim Biotech S.A. produces and sells instruments and consumables for the biopharmaceutical industry worldwide. The company offers various products, such as cell lines; cell culture media; bioreactors; and a range of products for separation, purification, and concentration processes, as well as products and systems for storage and transportation of intermediate and finished biological products. It also provides cell cultivation, fermentation, filtration, purification, and fluid management services; single-use and reusable hollow-fiber membrane devices, as well as presterilized assemblies for cell and gene therapy applications; and cell harvesting and various other solutions for intensified bioprocesses. In addition, the company offers data analytics software for modeling and optimizing processes of biopharmaceutical development and production. It serves manufacturers of pharmaceuticals, foods, and chemicals, as well as research and development laboratories. The company was founded in 1870 and is headquartered in Aubagne, France. Sartorius Stedim Biotech S.A. is a subsidiary of Sartorius AG.

Visit Website

Earnings History & Surprises

SDMHF

Beat Rate

21%

Last 19 quarters

Avg Surprise

-27.9%

EPS vs Estimate

Beats / Misses

4/15

Last 12 quarters

Latest EPS

$0.91

Q4 2025

EPS Surprise History

Q1 24

-46.2%

$0.47vs$0.88

Q2 24

-35.9%

$0.62vs$0.97

Q3 24

-50.8%

$0.53vs$1.07

Q4 24

-67.6%

$0.29vs$0.89

Q1 25

-50.3%

$0.49vs$0.98

Q2 25

-5.4%

$0.96vs$1.02

Q3 25

-33.4%

$0.81vs$1.22

Q4 25

-21.1%

$0.91vs$1.15

Beat Estimate

Missed Estimate

Quarterly EPS Details

Period	Report Date	Estimated EPS	Actual EPS	Surprise	Result
Q1 2026	Feb 16, 2026	—	—	—	—
Q4 2025	Oct 16, 2025	$1.15	$0.91	-21.1%	✗ MISS
Q3 2025	Jul 22, 2025	$1.22	$0.81	-33.4%	✗ MISS
Q2 2025	Apr 16, 2025	$1.02	$0.96	-5.4%	✗ MISS
Q1 2025	Jan 28, 2025	$0.98	$0.49	-50.3%	✗ MISS
Q4 2024	Oct 17, 2024	$0.89	$0.29	-67.6%	✗ MISS
Q3 2024	Jul 18, 2024	$1.07	$0.53	-50.8%	✗ MISS
Q2 2024	Apr 18, 2024	$0.97	$0.62	-35.9%	✗ MISS
Q1 2024	Jan 26, 2024	$0.88	$0.47	-46.2%	✗ MISS
Q3 2023	Sep 30, 2023	$2.95	$0.29	-90.0%	✗ MISS
Q2 2023	Jun 30, 2023	$2.33	$1.58	-32.2%	✗ MISS
Q1 2023	Mar 31, 2023	$3.43	$1.31	-61.8%	✗ MISS
Q1 2023	Feb 17, 2023	$2.30	$2.20	-4.3%	✗ MISS
Q4 2022	Oct 19, 2022	$2.97	$2.14	-27.9%	✗ MISS
Q3 2022	Jul 21, 2022	$3.31	$2.24	-32.3%	✗ MISS
Q2 2022	Apr 21, 2022	$2.98	$2.39	-19.8%	✗ MISS
Q1 2022	Jan 27, 2022	$2.04	$2.17	+6.4%	✓ BEAT
Q4 2021	Oct 20, 2021	$2.13	$2.36	+10.8%	✓ BEAT
Q3 2021	Jul 21, 2021	$1.83	$2.18	+19.1%	✓ BEAT
Q2 2021	Apr 21, 2021	$1.75	$1.98	+13.1%	✓ BEAT

Frequently Asked Questions about SDMHF

What is SDMHF's current stock price?

Sartorius Stedim Biotech S.A. (SDMHF) is currently trading at $240.00 per share. The stock has moved +0.00% today.

What is the analyst price target for SDMHF?

No analyst price targets are currently available for this stock.

What sector is Sartorius Stedim Biotech S.A. in?

Sartorius Stedim Biotech S.A. operates in the Healthcare sector, specifically within the Medical - Instruments & Supplies industry. The company is traded on the OTC exchange.

What is SDMHF's market cap?

Sartorius Stedim Biotech S.A. has a market capitalization of $23.34 billion, making it a large-cap company.

Does SDMHF pay dividends?

No, Sartorius Stedim Biotech S.A. does not currently pay a dividend to shareholders.